Unlearn

Home
LinkedIn
X
Unlearn.ai
Archive
About
Unlearn is SOC2 Type II Certified
By Hassaan Malik, Jack Giddings, & Zain Subedar
 • 
Unlearn

April 2024

From chaos to clarity: Unlearn’s quest to build the ultimate clinical dataset
Evan Estola, Head of Data
 • 
Unlearn
Advancements in Digital Twin Generators: A Leap Forward in Inflammation and Immunology Research
By Cary Murray, Frank Fuller, and Eric W. Tramel, Machine Learning Engineers
 • 
Unlearn

March 2024

Adding more power to Phase 2 clinical trials with our latest TwinRCT update
By Rachel Kalmar, Principal Product Manager
 • 
Unlearn
The Bitter Lesson of Domain Knowledge
By Charles Fisher, Founder and CEO at Unlearn.AI
 • 
Unlearn
3

February 2024

Introducing our Digital Twin Generators for Hypertension, Dyslipidemia, and Type-2 Diabetes
by Eric Tramel, Frank Fuller, and Cary Murray, ML team extraordinaire
 • 
Unlearn
Damn the torpedoes!
By Charles Fisher, Founder & CEO, Unlearn.AI
 • 
Unlearn

January 2024

Pioneering change in pharma by cultivating first followers
By Andrew Stelzer, Head of Business Development
 • 
Unlearn
US FDA comments on Unlearn’s PROCOVA methodology
By Charles Fisher, Founder and CEO, Unlearn.AI
 • 
Unlearn

November 2023

Why Moore’s law will eat Eroom’s law
Charles Fisher, Founder and CEO, Unlearn.AI
 • 
Unlearn
1
Announcing the latest release of our Parkinson’s Disease Digital Twin Generator
By Cary Murray, Dimitri Theoharatos, Machine Learning Engineers, and Eric Tramel, Tech Lead
 • 
Unlearn
How we approach data processing at Unlearn: Part 2
By Ryan Douglas and Anil Tolwani, Ace Data Scientists
 • 
Unlearn
© 2024 Unlearn
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture